Lv2
120 积分 2025-04-28 加入
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
22小时前
已完结
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
23小时前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
1个月前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
1个月前
已完结
中国大陆部分地区局部晚期宫颈癌治疗状况调查及分析
2个月前
已完结
局部晚期宫颈癌（ⅠB3及ⅡA2期）手术综合治疗与同步放化疗的回顾性研究
2个月前
已完结
皖公网安备34019202002308
